Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Corcept Therapeutics (CORT) Other Operating Expenses: 2009-2024

Historic Other Operating Expenses for Corcept Therapeutics (CORT) over the last 10 years, with Dec 2024 value amounting to $10.9 million.

  • Corcept Therapeutics' Other Operating Expenses rose 60.31% to $4.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.4 million, marking a year-over-year increase of 36.57%. This contributed to the annual value of $10.9 million for FY2024, which is 67.91% up from last year.
  • According to the latest figures from FY2024, Corcept Therapeutics' Other Operating Expenses is $10.9 million, which was up 67.91% from $6.5 million recorded in FY2023.
  • Over the past 5 years, Corcept Therapeutics' Other Operating Expenses peaked at $14.0 million during FY2022, and registered a low of $5.3 million during FY2021.
  • Over the past 3 years, Corcept Therapeutics' median Other Operating Expenses value was $10.9 million (recorded in 2024), while the average stood at $10.5 million.
  • In the last 5 years, Corcept Therapeutics' Other Operating Expenses soared by 165.10% in 2022 and then slumped by 53.71% in 2023.
  • Corcept Therapeutics' Other Operating Expenses (Yearly) stood at $5.6 million in 2020, then fell by 5.39% to $5.3 million in 2021, then surged by 165.10% to $14.0 million in 2022, then slumped by 53.71% to $6.5 million in 2023, then spiked by 67.91% to $10.9 million in 2024.